Sarepta Therapeutics (SRPT) PT Lowered to $184 at Oppenheimer
Tweet Send to a Friend
(Updated - April 7, 2025 8:25 AM EDT)
Oppenheimer analyst Hartaj Singh lowered the price target on Sarepta Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Hartaj Singh lowered the price target on Sarepta Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
